MEDVIA: paving the way for health innovation There is a lot of money being invested in health innovation in Flanders, yet companies consistently run into the same […] March 13, 2023 · BioVox
How to integrate patient perspectives in innovation After recovering from metastatic colon cancer, Stefan Gijssels became a patient advocate dedicated to improving the healthcare system that saved […] February 22, 2023 · BioVox
Femtech: Breaking barriers in women’s health through innovation and investment Femtech is a growing field that has rapidly expanded from niche market to global ecosystem. From period-tracking apps and smart […] February 22, 2023 · BioVox
The hype cycle in life sciences investments: go with the flow or fight the current? Everyone in the investment business is familiar with the phenomenon of technology hypes. These trends tend to come and go […] February 22, 2023 · V-Bio Ventures
Data science – taking clinical drug development to the next level Clinical drug development is a challenging endeavor, but help is at hand! From trial site selection, to patient recruitment, to […] February 22, 2023 · Janssen Pharmaceutica
The chaos of choice: how do people pick their food products? Every family needs groceries, and most people regularly venture to the supermarket to gather supplies. If researchers can help shoppers […] January 25, 2023 · SciMingo
Why diversity matters in management teams, and how to achieve it The biotech industry is suffering from a serious talent shortage, with start-ups in particular having an increasingly hard time filling […] December 14, 2022 · V-Bio Ventures
MedTech Flanders becomes part of MEDVIA, Flanders’ healthtech spearhead cluster Ghent, Belgium, 13 December 2022 – MEDVIA was founded in 2021 as Flanders’ spearhead cluster focused on health technologies. It is […] December 13, 2022 · Turnstone Communications
From multiple pills per day to one treatment per month: progress in HIV medication made possible by pharma collaborations Unprecedented collaborations between different pharmaceutical companies have resulted in extraordinary progress for HIV patients over the past four decades. From […] December 5, 2022 · Janssen Pharmaceutica
Data science in early drug discovery – getting it right from the start The application of data science in the early stages of drug development is not new – progress in algorithms and […] November 24, 2022 · Janssen Pharmaceutica
Cancer vaccines: not only treating tumors, but preventing them too The COVID-19 pandemic has brought vaccines back into the drug development spotlight, and mRNA vaccines are stealing the show with […] November 23, 2022 · V-Bio Ventures
Gene therapy challenges and the solutions in sight Dr. Federico Mingozzi is the CSO of Spark Therapeutics, the company behind Luxturna – the world’s first FDA-approved gene therapy […] October 19, 2022 · BioVox
We need more food and agtech start-ups – and we need them now! How are we going to feed an expected 10 billion people by 2050 in a sustainable way? It is a […] October 19, 2022 · V-Bio Ventures
BioVox: shining a light on Belgian biotech Beer, chocolate, and… biotech! When it comes to life sciences, Belgium excels. It consistently ranks as one of the world’s […] October 19, 2022 · BioVox
VC opportunities for impact in the face of climate disaster Venture capitalists have a vital role to play in guiding our planet’s future. By investing in technological advances that remediate […] September 7, 2022 · V-Bio Ventures